Table 1.
Characteristic | N = 1500 |
---|---|
Mean ± SD age, years | 64.8 ± 12.3 |
Gender, n (%) | |
Male | 810 (54) |
Female | 690 (46) |
Karnofsky index score, mean ± SD | 61.1 ± 18.2 |
Place of assessment, n (%) | |
Outpatient clinic | 549 (37) |
Day hospital | 171 (11) |
Home care | 232 (15) |
Hospice | 47 (3) |
Hospital inpatient ward | 501 (33) |
Primary tumor site, n (%) | |
Lung | 352 (22) |
Urogenital | 254 (17) |
Gastrointestinal | 276 (18) |
Breast | 201 (13) |
Pancreas | 129 (8) |
Liver | 16 (1) |
Head and neck | 97 (6) |
Others | 241 (15) |
Disease, n (%) | |
Locoregional | 250 (17) |
Metastatic | 1250 (83) |
Previous anticancer treatment, n (%)a | 1154 (79) |
Care setting, n (%) | |
Palliative care | 289 (19) |
Oncology | 672 (45) |
Pain therapy | 526 (35) |
Radiotherapy | 13 (1) |
All values are presented as mean ± SD or number of patients (proportion of patients)
SD standard deviation
aData available in 1464 patients